Purpose: It is unclear whether protein supplementation augments the gains in muscle strength and size observed following resistance training (RT), as limitations to previous studies include small cohorts, imprecise measures of muscle size and strength, and no control of prior exercise or habitual protein intake (HPI). We aimed to determine whether whey protein supplementation affected RT-induced changes in elbow flexor muscle strength and size. Methods: We pair-matched 33 previously untrained, healthy young men for their HPI and strength response to 3-wk RT without nutritional supplementation (followed by 6-wk no training), and then randomly 
INTRODUCTION
Paragraph Number (PN) 1: Both resistance exercise (4) and protein ingestion (31) are known to stimulate muscle protein synthesis (MPS), which is necessary for the accretion of skeletal muscle mass. Moreover, combining protein or amino acid ingestion with an acute bout of resistance exercise has been shown to further augment MPS (32) . Based on these acute studies, it is surprising that the evidence for protein supplementation (PRO) enhancing the gains in muscle size and strength following longer term RT programs in young men remains equivocal (17, 24) .
PN 2:
It has been suggested that the muscle strength (9, 40) and size (1, 17) responses to RT in young men may be amplified by PRO, although these effects are often marginal (20) . In contrast, other studies in young men have shown no effect of PRO on gains in muscle size (8, 24) or strength (1, 24) . Greater increases in muscle fiber area (1, 17) and myofibrillar protein content (40) have been observed when RT was combined with PRO rather than carbohydrate. However, none of these studies included detailed measurements of whole muscle size.
PN 3:
The apparent discrepancy between the acute studies of a single training bout and the longer-term RT studies may be compounded by a range of methodological issues with the latter. Firstly, the individual response to RT is known to vary widely between individuals (13, 19) , yet numerous studies have used small participant groups (16, 20, 40) that may not have been powered to detect an influence of PRO. The impact of inter-individual variability might also be reduced by greater experimental control of prior physical activity and habitual protein intake. Secondly, some studies have used crude measures of muscle hypertrophy, such as dual-energy X-ray absorptiometry to assess whole body fat-free mass (17) or muscle thickness determined with ultrasonography (7, 35) . Thirdly, in the context of nutritional supplementation, no study has attempted to minimize or quantify the neural changes that occur with RT, which together with muscle hypertrophy, are considered the major contributors to strength improvements (15) . Thus, large and variable neural improvements could have confounded the potential influence of PRO on traininginduced changes in muscle size and strength in previous studies. Finally, the resistance exercise model that has been most commonly researched has involved lower limb training (1, 8, 34) despite the upper limb musculature showing greater adaptive responses to resistance training (10, 37) . Therefore, an elbow flexor exercise model may offer a better chance of discriminating an influence of PRO on muscle hypertrophy and strength changes following RT.
PN 4:
Taking all the above factors into account, we aimed to compare the traininginduced changes in elbow flexor muscle size, architecture and strength between two groups of previously untrained young men supplemented with either protein or placebo. We hypothesized that 20 g (26) whey protein (31) ingested immediately before (33) and after (14) each training session would confer greater changes in muscle size and strength after 12 weeks of RT, compared to RT alone.
METHODS

Participants
PN 5:
Thirty-three healthy young men (mean ± SD: age, 23 ± 3 yrs; height, 1.76 ± 0.06 m; body mass, 75.2 ± 10.7 kg) provided written informed consent prior to completing this 25-week study, which complied with the Declaration of Helsinki and was approved by the Ethical Advisory Committee of Loughborough University.
Volunteers were excluded from taking part in the study if they: were vegans; had unusually high (>2 g⋅kg -1 ⋅day -1 ) or low (<0.8 g⋅kg
reported use of potentially anabolic supplements in the previous 6 months or were taking any medication considered to influence muscle size or function; had a history of upper body exercise in the previous 12 months; were <18 or >30 yrs old.
Study overview
PN 6:
The study was a single-centre, double-blind design. Participants completed 3-wk elbow flexor RT without nutritional supplementation, 6-wk of no training, and then 12-wk elbow flexor RT with nutritional supplementation (Fig. 1A) . The 3-wk RT period was conducted to standardize training status prior to the 12-wk RT, and to overcome neural adaptations that occur within the first few weeks of RT (27) . The 6-wk of no training provided a clear break between the training periods to improve participant retention, and has been shown to result in only a modest detraining effect (23) . During the 6-wk no RT participants were pair-matched for their isometric strength response to the 3-wk RT and their normal protein intake (Table 1) , and randomly assigned to PRO (n = 17) or PLA (n = 16) supplementation groups. The groups had similar age, elbow flexor muscle strength and size, anthropometric, physical activity and nutritional characteristics (Table 1) . Participants then completed 12-wk RT, during which they received PRO or PLA supplementation. Measurements of the dominant arm were performed before and 3-4 days after the 12-wk RT in the following order: muscle architecture (assessed with ultrasonography); dynamic and isometric strength (agonist and antagonist muscle activation was determined with sEMG); muscle size was assessed with magnetic resonance imaging (MRI) at least 24-h after strength testing to ensure that measurements were not influenced by exercise-induced fluid shifts. All testing took place between 09:00 and 18:00 and, for each participant, tests were performed at the same time of day before and after training. Participants were instructed not to participate in strenuous physical activity, consume alcohol or excessive amounts of caffeine in the 24-hr prior to measurement sessions, and to maintain their habitual diet and lifestyle throughout the study. 
Neuromuscular measurements and protocol
Muscle architecture were performed interspersed with 1 min rest intervals, firstly at the previous 1-RM, and then at increments of +0.5 kg if the preceding lift was successful. The 1-RM was generally determined within 3-5 attempts, although more attempts were completed if necessary. The test-retest CV for this assessment was 3.5%.
Isometric maximum voluntary force (MVF)
PN 11: Elbow flexor isometric strength was measured using a custom-built strengthtesting chair ( therefore, the assessment of muscle activation. Further, % body fat was calculated from the sum of these four skin-folds (11, 30) and used to calculate fat-free mass. The test-retest CV for the assessment of % body fat was 0.8%. Habitual physical activity level (PAL) was assessed from a standard questionnaire (2) that was completed at the start and end of the whole study protocol (Fig. 1A) . Bivariate relationships were assessed with Pearson's product moment correlations and statistical significance was defined as P < 0.05. to 454.8 ± 81.5 cm 3 (+14.9 ± 4.6%) for PLA, with no significance difference between the two groups (ANOVA, time P < 0.001, group x time P = 0.52; Table 2 ). The training-induced change in volume of the individual elbow flexors also showed no effect of supplementation group (ANOVA, group x time: BB, P = 0.86; BRACH, P = 0.68; BR, P = 0.77; Fig. 2A ; Table 2 ).
Statistical analysis
PN
RESULTS
Muscle
PN 18:
∑ACSA max also displayed a clear effect of the training from 26.9 ± 4.3 to 31.3 ± 5.1 cm 2 (+16.2 ± 7.1%) for PRO and from 28.5 ± 3.9 to 32.9 ± 4.5 cm 2 (+15.6 ± 4.4%) for PLA, but no difference between the groups (ANOVA, time P < 0.001, group x time P = 0.87; Table 2 ). Similarly, the changes in ACSA max for each of the individual elbow flexor muscles were not influenced by supplementation (ANOVA, group x time 0.53 < P < 0.95; Table 2 ).
PN 19:
Training increased muscle fascicle θ p of the BBS and BRACH in both the PRO (BBS, 18.5 ± 9.5%; BRACH, 15.7 ± 9.9%) and PLA (BBS, 15.8 ± 6.9%; BRACH, 14.6 ± 8.2%) supplementation groups, but these changes did not differ between the groups (ANOVA, group x time 0.65 < P < 0.89; Table 2 ). BBS, P = 0.049; BR P = 0.17; Table 3 ), but there were similar changes in M max and hence normalized sEMG was unchanged after training (ANOVA, time, BBL P = 0.173; BBS, P = 0.56; Table 3 ). There was no interaction between supplementation group and RT for agonist sEMG (ANOVA, group x time: absolute values, 0.11 < P < 0.80; normalized values, 0.60 < P < 0.95; Table 3 ). The percentage change in sEMG at isometric MVF also showed no difference between groups for the individual agonist muscles (Table 3) . When data were collapsed across the agonist muscles there were no differences between the % changes recorded for the supplementation groups (absolute values: PLA, -9.5 ± 17.5% vs. PRO, -2.5 ± 27.6%, t-test P = 0.41; normalized values: PLA, 6.1 ± 34.1% vs. PRO, 0.0 ± 34.9%, t-test P = 0.63).
Antagonist sEMG at elbow flexion MVF was unchanged in both groups (ANOVA, group x time: absolute values, P = 0.09; normalized values, P = 0.65). Table 4 ). However, when supplement intake was averaged across training and non-training days, total protein intake was similar for both groups (absolute values; t-test, P = 0.09; normalized to body mass; ttest, P = 0.12; Table 4 ), and carbohydrate, fat and total energy intake remained similar (t-test, P ≥ 0.47; Table 4 ). 60.2 ± 10.2 to 60.2 ± 9.6 kg; PRO, 57.9 ± 7.5 to 58.2 ± 7.1 kg).
PN 24:
Prior to performing the 3-wk RT, the whole cohort had a PAL of 2.6 ± 0.4 indicating that they were 'recreationally active', and it remained stable over the course of the study (post 12-wk RT, 2.6 ± 0.4). There was no difference in PAL between PLA and PRO (ANOVA, time P = 0.36, group x time P = 0.48), and the mean PAL (pre and post) was unrelated to any of the training responses following the 12-wk RT (R 2 ≤ 0.06; P ≥ 0.17). 
PN 26:
There are a number of factors in our study that we thought would accentuate an effect of PRO on the training-induced changes in muscle size and strength: 1) it featured larger cohorts than have been used in most previous studies of this kind; 2)
an initial pre-intervention RT period was included to overcome neural changes, standardize pre-intervention training status and familiarize participants with all training and measurement procedures; 3) participants included only young, healthy male participants that might be more responsive to RT (37) and PRO (36) 
PN 27:
The ~16% changes in elbow flexor muscle volume and maximum ACSA observed in this study were similar to the 14-23% changes reported in previous upper limb RT studies (10, 19, 37) . In spite of these substantial changes, there was no difference in muscle hypertrophy between PRO and PLA groups. Accepting the methodological differences between studies, this finding is broadly similar to previous investigations in young men (8, 20) , post-menopausal women (18) and older people (34) , which used MRI (8, 18, 20) or computer tomography (34) to quantify changes in lower-limb muscle ACSA following RT supplemented with PRO or PLA. The lowerlimb nature of these previous strength training studies resulted in markedly smaller changes in muscle size (5-10%) compared to those reported in our study, and thus may have restricted their capacity to determine any hypertrophic benefit of PRO.
However, despite using a more responsive muscle group, our results suggest that PRO does not amplify the hypertrophic adaptation to RT.
PN 28:
In contrast, some previous studies have used other measures of muscularity, such as dual-energy X-ray absorptiometry to assess lean body mass (17) and ultrasonography to measure muscle thickness (7), and have found a positive effect of PRO following a period of RT. However, these methods are widely considered to have lower precision and reliability than MRI (3). Furthermore, other RT studies have reported no difference between PRO and PLA regarding changes in either lean body mass (34) or muscle thickness (35) . By measuring muscle fiber CSA (fCSA), the effect of PRO on RT-induced muscle hypertrophy has been determined at the cellular level but with contradictory findings (1, 17, 18, 34) . The lack of concurrence may reflect the large variability in the histological measurement of fCSA from biopsy samples (25) that may not mirror training-induced changes in whole muscle size measured with MRI (28).
PN 29:
We observed significant increases in biceps brachii and brachialis muscle fascicle pennation angle (θ p ) in both PRO and PLA groups but no difference between groups. These findings are in accord with the relative changes in whole muscle volume and ACSA max observed in both training groups but are in contrast to those of a previous RT study that reported an increase in gastrocnemius medialis θ p in participants supplemented with essential amino acids and no change in PLA (35) . This is surprising, especially as RT is known to increase muscle θ p even when no nutritional supplementation is provided (13).
PN 30:
Together with muscle hypertrophy, neural changes are considered to be the major contributors to strength improvements following RT (15) and the current study was the first to quantify the neural adaptations to RT in the context of PRO. Voluntary muscle activation and antagonist muscle co-activation, assessed with normalized sEMG, did not change following 12 weeks elbow flexion RT in either group. This finding suggests that elbow flexor muscle activation was very high prior to the 12-wk RT period, and that neural adaptations did not confound any potential effect of PRO on the strength gains found in this study.
PN 31:
Following the 12-wk supplemented RT, elbow flexor 1-RM increased by ~41% and isometric strength by ~13%, changes that are in accord with previous RT studies on the elbow flexor muscle group (10). However, given that there were no differences in neural adaptations or muscle morphology between PRO and PLA groups, it was not surprising that RT-induced strength gains did not differ between the two groups. This finding is similar to that reported in previous RT studies of the lower limb (1, 17, 34) but different to those reporting a significant effect of PRO on RTinduced increases in 1-RM (8, 9) . Although the reasons for these discrepancies are not clear, changes in 1-RM are probably influenced by neural adaptations and the involvement of stabilizer muscles (29), which were not accounted for in these studies and may have confounded their results.
PN 32:
Normal dietary behavior, as assessed from two 3-day records of weighed nutrient intake, was similar for the PRO and PLA groups both before and during the 12-wk supplemented RT period, and there was no change over time. Therefore, it seems unlikely that this could have confounded our findings. However, we acknowledge that a longer recording period and/or additional assessments of weighed nutrient intake might have provided a more comprehensive account of habitual diet and further reinforced our results. Based on the available evidence, we considered that whey protein as opposed to soy or casein (31) , supplemented immediately before and after each session (14, 33) , as well as a dosage of ≥20 g (26) , would promote MPS, and maximize the hypertrophic response. The conventional PRO supplementation approach of this study, i.e. targeted at the time of training, did influence protein intake on training days, but did not affect total protein intake averaged over training and non-training days. It is possible, therefore, that influencing total protein intake could be an important factor in any benefits of PRO, although several previous studies that also found no influence of training targeted PRO on total protein intake (17, 20) 
